CDC Advisory Panel Recommends Use Of Nirsevimab To Prevent RSV In Infants, Toddlers

August 04, 2023

Reuters (8/3, Dey, Sunny) reports the CDC “said its advisory panel on Thursday recommended use of Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.” The Advisory Committee on Immunizati...